tno.nl
Cure8 news brief
Why This Matters
This project aims to develop wearable-based digital biomarkers to detect IBD flares earlier and make remote monitoring easier, which could help patients and clinicians manage disease more proactively. It describes planned studies and partnerships but does not report clinical results yet.
Who Should Pay Attention
People living with IBD, patient advocates, clinicians involved in IBD care, digital health researchers, and industry partners working on wearables or biomarkers.
Study Snapshot
Story typeResearch news
Evidence typeClinical study
Source depthFull source text
What To Know
The IBDigital project launched at ECCO aims to develop wearable-driven digital biomarkers to detect IBD flares earlier and support remote monitoring.
Partners include academic centers, patient groups, medtech firms, and pharmaceutical companies; the project will run a three-year program with retrospective data work, co-design with patients, and a longitudinal wearable study.
The project emphasizes passive data (heart rate variability, sleep, activity) to reduce questionnaire burden and improve inclusivity. It plans to validate a clinically useful digital biomarker and create an adoption roadmap for wider clinical use.
Keep In Mind
This is an announcement of a multi-year research and development program (public–private partnership). The article outlines planned retrospective analyses, co-design with patients, and a longitudinal wearable study — it does not present validated biomarker results or clinical recommendations yet.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationtno.nl
Indexed viaBing News
Source typeResearch news
PublishedMar 6, 2025, 5:54 AM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Mobius Care Receives Funding from Crohn's & Colitis Foundation
A validated AI biomarker that predicts which IBD treatments are likely to work could reduce trial-and-error in treatment choices, potentially shortening time to effective therapy for people with Crohn's disease or...
Is There a Blood Test That Distinguishes Crohn's Disease From UC? - HealthCentral
Distinguishing Crohn’s from ulcerative colitis can be hard and often requires invasive tests. A reliable blood test would speed diagnosis and help patients start the right treatments sooner. This study is an early step...
Crosstalk between circRNAs and the classic signaling pathways in IBD.
Researchers are exploring circRNAs as new molecular players in IBD inflammation; that could lead to future biomarker tests or novel treatments targeting immune pathways relevant to Crohn’s disease and ulcerative colitis.